BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26289001)

  • 1. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016; 42(3):446-55. PubMed ID: 26289001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
    Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
    Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
    Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K
    Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous Solid Dispersions of Felodipine and Nifedipine with Soluplus®: Drug-Polymer Miscibility and Intermolecular Interactions.
    Sarpal K; Munson EJ
    J Pharm Sci; 2021 Apr; 110(4):1457-1469. PubMed ID: 33359813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
    Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
    Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two DSC-based methods to predict drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Int J Pharm; 2018 Apr; 540(1-2):98-105. PubMed ID: 29425764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug.
    Mamidi HK; Rohera BD
    J Pharm Sci; 2021 Jul; 110(7):2703-2717. PubMed ID: 33609521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory.
    Bansal K; Baghel US; Thakral S
    AAPS PharmSciTech; 2016 Apr; 17(2):318-27. PubMed ID: 26092302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S; Cathcart H; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System.
    Potter CB; Davis MT; Albadarin AB; Walker GM
    Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of acetaminophen's solubility in poly(ethylene oxide) at room temperature using the Flory-Huggins theory.
    Yang M; Wang P; Gogos C
    Drug Dev Ind Pharm; 2013 Jan; 39(1):102-8. PubMed ID: 22356356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of miscibility analysis and determination of Soluplus solubility map for development of carvedilol-loaded nanofibers.
    Kaljević O; Djuris J; Čalija B; Lavrič Z; Kristl J; Ibrić S
    Int J Pharm; 2017 Nov; 533(2):445-454. PubMed ID: 28495583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
    Marsac PJ; Li T; Taylor LS
    Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).
    Hu Z; Xu P; Ashour EA; Repka MA
    AAPS PharmSciTech; 2022 Jun; 23(6):169. PubMed ID: 35715519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.